nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—neck—pharynx cancer	0.0832	0.126	CbGeAlD
Masoprocol—IGF1R—brainstem—pharynx cancer	0.0636	0.0966	CbGeAlD
Masoprocol—LTB4R—trachea—pharynx cancer	0.0606	0.0922	CbGeAlD
Masoprocol—IGF1R—epithelium—pharynx cancer	0.0566	0.0861	CbGeAlD
Masoprocol—LTB4R—lymphoid tissue—pharynx cancer	0.0528	0.0803	CbGeAlD
Masoprocol—CYP2J2—parotid gland—pharynx cancer	0.0459	0.0698	CbGeAlD
Masoprocol—IGF1R—lymphoid tissue—pharynx cancer	0.0436	0.0663	CbGeAlD
Masoprocol—IGF1R—head—pharynx cancer	0.0351	0.0534	CbGeAlD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0344	0.1	CbGpPWpGaD
Masoprocol—CYP2J2—trachea—pharynx cancer	0.0339	0.0516	CbGeAlD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0302	0.0881	CbGpPWpGaD
Masoprocol—LTB4R—lymph node—pharynx cancer	0.0298	0.0453	CbGeAlD
Masoprocol—CYP2J2—spinal cord—pharynx cancer	0.0268	0.0407	CbGeAlD
Masoprocol—IGF1R—lymph node—pharynx cancer	0.0246	0.0374	CbGeAlD
Masoprocol—CYP2J2—head—pharynx cancer	0.0238	0.0362	CbGeAlD
Masoprocol—ALOX5—lymphoid tissue—pharynx cancer	0.0233	0.0354	CbGeAlD
Masoprocol—CYP2J2—Biological oxidations—CNDP2—pharynx cancer	0.0202	0.059	CbGpPWpGaD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—CDH1—pharynx cancer	0.0197	0.0575	CbGpPWpGaD
Masoprocol—ALOX5—head—pharynx cancer	0.0188	0.0285	CbGeAlD
Masoprocol—CYP2J2—Biological oxidations—ADH7—pharynx cancer	0.0183	0.0534	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—pharynx cancer	0.0177	0.0516	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—ADH1B—pharynx cancer	0.016	0.0468	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0158	0.0461	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0139	0.0405	CbGpPWpGaD
Masoprocol—ALOX5—lymph node—pharynx cancer	0.0131	0.02	CbGeAlD
Masoprocol—CYP19A1—head—pharynx cancer	0.013	0.0197	CbGeAlD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—EGFR—pharynx cancer	0.0115	0.0336	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—pharynx cancer	0.0103	0.0302	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CNDP2—pharynx cancer	0.00928	0.0271	CbGpPWpGaD
Masoprocol—CYP19A1—lymph node—pharynx cancer	0.00908	0.0138	CbGeAlD
Masoprocol—IGF1R—SHP2 signaling—EGFR—pharynx cancer	0.00889	0.026	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.00859	0.0251	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—ADH7—pharynx cancer	0.00839	0.0245	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CCND1—pharynx cancer	0.00755	0.022	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—ADH1B—pharynx cancer	0.00736	0.0215	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00674	0.0197	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—EGFR—pharynx cancer	0.00592	0.0173	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00566	0.0165	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TP53—pharynx cancer	0.00555	0.0162	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—pharynx cancer	0.00497	0.0145	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.00464	0.0136	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND1—pharynx cancer	0.00438	0.0128	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00366	0.0107	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CNDP2—pharynx cancer	0.00346	0.0101	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—pharynx cancer	0.00344	0.01	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADH7—pharynx cancer	0.00313	0.00913	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CNDP2—pharynx cancer	0.00308	0.009	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADH7—pharynx cancer	0.00279	0.00814	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADH1B—pharynx cancer	0.00274	0.008	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—B4GALT5—pharynx cancer	0.00262	0.00765	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADH1B—pharynx cancer	0.00244	0.00713	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00238	0.00696	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—B4GALT5—pharynx cancer	0.00233	0.00682	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00178	0.00519	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CNDP2—pharynx cancer	0.00159	0.00463	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADH7—pharynx cancer	0.00144	0.00419	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00139	0.00407	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADH1B—pharynx cancer	0.00126	0.00368	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—B4GALT5—pharynx cancer	0.0012	0.00351	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00117	0.00342	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—pharynx cancer	0.00106	0.0031	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—pharynx cancer	0.000798	0.00233	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—pharynx cancer	0.000679	0.00198	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—pharynx cancer	0.000626	0.00183	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—pharynx cancer	0.000533	0.00156	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—pharynx cancer	0.000526	0.00154	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—pharynx cancer	0.000447	0.00131	CbGpPWpGaD
